AbbVie Loses Chancery Fight For Takeda Contract Injunction
AbbVie Endocrine Inc. has lost a bid for a Delaware Chancery Court injunction that would bind Japan's Takeda Pharmaceutical Co. Ltd. to North American delivery targets for a globally important drug...To view the full article, register now.
Already a subscriber? Click here to view full article